oral semaglutide 50 mg Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients OASIS 2 Trial: Oral Semaglutide

SELENOW also appears to be a negative regulator for 14-3-3 proteins

Insights into Vitamin D metabolism using cyp24 overexpression and knockout systems in conjunction with liquid chromatography/mass spectrometry (LC/MS)

Between December 2025 and January 2026, both of these MDLs gained new plaintiffs

Age, sex, and metabolic health status also play roles, with some evidence suggesting that younger patients and those without significant metabolic comorbidities may respond more rapidly

as well as the hippocampus

Full hormonal clearance, meaning all downstream signaling has resolved, occurs within 3-4 days after your final dose